Tenax Therapeutics (TENX) Change in Interest Receivables (2020 - 2022)
Tenax Therapeutics (TENX) reported Change in Interest Receivables of -$1484.0 for Q2 2022, down 341.67% on a YoY basis from $614.07 in Q2 2021, and up 42.64% sequentially from -$2587.0 in Q1 2022.
Tenax Therapeutics (TENX) Change in Interest Receivables (2020 - 2022) Analysis & Trends
Tenax Therapeutics (TENX) has 3 years of Change in Interest Receivables data on file, last reported at -$1484.0 in Q2 2022.
- For the quarter ending Q2 2022, Change in Interest Receivables fell 341.67% year-over-year to -$1484.0; the trailing twelve-month figure through Jun 2022 stood at -$4071.0 (down 36.52% YoY), and the FY2021 full-year result was -$949.0, up 41.67% from the prior year.
- Change in Interest Receivables climbed to -$1484.0 in Q2 2022, from -$2587.0 in the prior quarter.
- In the past five years, Change in Interest Receivables ranged from a high of $1898.0 in Q3 2021 to a low of -$2643.0 in Q4 2020.
- A 3-year average of -$738.56 and a median of -$613.0 in 2021 frame the typical range for Change in Interest Receivables.
- Across the five-year window, Change in Interest Receivables surged 211.15% in 2021 and slumped 341.67% in 2022, its largest moves.
- Tracing TENX's Change in Interest Receivables over 3 years: stood at -$2643.0 in 2020, then rose by 28.19% to -$1898.0 in 2021, then grew by 21.81% to -$1484.0 in 2022.
- Business Quant data shows TENX's Change in Interest Receivables at -$1484.0 in Q2 2022, -$2587.0 in Q1 2022, and -$1898.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,484.00 |
| Mar 31, 2022 | -2,587.00 |
| Dec 31, 2021 | -1,898.00 |
| Sep 30, 2021 | 1,898.00 |
| Jun 30, 2021 | -336.00 |
| Mar 31, 2021 | -613.00 |
| Dec 31, 2020 | -2,643.00 |
| Sep 30, 2020 | 610.00 |
| Jun 30, 2020 | 406.00 |